Evidence map›Paper›PMID 23052055›Full record

ArticleDiabetologia2013

Production and function of IL-12 in islets and beta cells.

D A Taylor-Fishwick, J R Weaver, W Grzesik, S Chakrabarti, S Green-Mitchell, Y Imai, N Kuhn, J L Nadler

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Transgenerational effects of maternal bisphenol: a exposure on offspring metabolic health.Journal of developmental origins of health and disease · 2019
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Islet inflammation: a unifying target for diabetes treatment?Trends in endocrinology and metabolism: TEM · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

D A Taylor-FishwickStrelitz Diabetes Center, Department of Internal Medicine, Eastern Virginia Medical School, 700 W. Olney Road, Norfolk, VA 23501, USA. Taylord@evms.edu
J R Weaver
W Grzesik
S Chakrabarti
S Green-Mitchell
Y Imai
N Kuhn
J L Nadler
Eastern Virginia Medical School · US

Funding

Role of Lipid Droplet Proteins in Islet Function in Diabetes and ObesityR01DK090490 · NIDDK · UNIVERSITY OF IOWA · PI IMAI, YUMI · 2011 to 2025
$5.0M
Role of the Interleukin12/STAT4 Pathway in Insulin Resistance and AtherosclerosisR01HL112605 · NHLBI · EASTERN VIRGINIA MEDICAL SCHOOL · PI NADLER, JERRY L. · 2012 to 2016
$2.0M
NHLBI NIH HHS HL112605NHLBI NIH HHS R01 HL112605NIDDK NIH HHS DK090490NIDDK NIH HHS R01 DK090490
6 · The paper itself

Abstract

aims/hypothesisIL-12 is an important cytokine in early inflammatory responses and is implicated in the immune-mediated pathogenesis of pancreatic islets in diabetes. However, little is known about the direct effects of IL-12 on islets and beta cells.

methodsIn this study, beta cell function, gene expression and protein production were assessed in primary human donor islets and murine beta cell lines in response to stimulation with IL-12 or a pro-inflammatory cytokine cocktail (TNF-α, IL-1β and IFN-γ).

resultsThe pro-inflammatory cytokine cocktail induced islet dysfunction and potently increased the expression and production of IL-12 ligand and IL-12 receptor in human islets. In human islets, the receptor for IL-12 co-localised to the cell surface of insulin-producing cells. Both IL-12 ligand and IL-12 receptor are expressed in the homogeneous beta cell line INS-1. IL-12 induced changes in gene expression, including a dose-dependent upregulation of IFNγ (also known as IFNG), in INS-1 cells. A neutralising antibody to IL-12 directly inhibited IFNγ gene expression in human donor islets induced by either IL-12 or pro-inflammatory cytokine stimulation. Functionally, IL-12 impaired glucose-stimulated insulin secretion (GSIS) in INS-1 cells and human donor islets. A neutralising antibody to IL-12 reversed the beta cell dysfunction (uncoupling of GSIS or induction of caspase-3 activity) induced by pro-inflammatory cytokines. CONCLUSIONS/

interpretationThese data identify beta cells as a local source of IL-12 ligand and suggest a direct role of IL-12 in mediating beta cell pathology.

Indexed as

Gene Expression RegulationSignal TransductionAnimalsAntibodies, NeutralizingCell LineCell MembraneCytokinesDiabetes Mellitus, Type 2HumansInsulinInsulin-Secreting CellsInsulin SecretionInterferon-gammaInterleukin-12Islets of LangerhansMiceAntibodies, NeutralizingCytokinesIFNG protein, humanInsulinInterferon-gammaInterleukin-12Receptors, Interleukin-12RNA, Messenger

Identifiers

PMID23052055
PMCPMC3651896
OpenAlexW1989367454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.